The Enterprise Value as of November 2024 (TTM) for Taro Pharmaceutical Industries Ltd. (TARO) is 1.25B

According to Taro Pharmaceutical Industries Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 1.25B. This represents a change of 3.03% compared to the average of 1.22B of the last 4 quarters.

Taro Pharmaceutical Industries Ltd. (TARO) Historical Enterprise Value (quarterly & annually)

How has TARO Enterprise Value performed in the past?

The mean historical Enterprise Value of Taro Pharmaceutical Industries Ltd. over the last ten years is 2.98B. The current 1.25B Enterprise Value has changed 4.10% with respect to the historical average. Over the past ten years (40 quarters), TARO's Enterprise Value was at its highest in in the September 2014 quarter at 6.35B. The Enterprise Value was at its lowest in in the March 2023 quarter at 761.52M.

Taro Pharmaceutical Industries Ltd. (TARO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Taro Pharmaceutical Industries Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Taro Pharmaceutical Industries Ltd. (TARO) Average Enterprise Value

How has TARO Enterprise Value performed in the past?

The current Enterprise Value of Taro Pharmaceutical Industries Ltd. (TARO) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Taro Pharmaceutical Industries Ltd. (TARO) Enterprise Value vs. Peers

How is TARO’s Enterprise Value compared to its peers?

Taro Pharmaceutical Industries Ltd.’s Enterprise Value is greater than Eagle Pharmaceuticals, Inc. (24.78M), less than ANI Pharmaceuticals, Inc. (1.68B), greater than Phibro Animal Health Corporation (1.20B), less than Deciphera Pharmaceuticals, Inc. (2.15B), less than Prestige Consumer Healthcare Inc. (5.20B), less than Amphastar Pharmaceuticals, Inc. (2.62B), greater than Pacira BioSciences, Inc. (1.21B), less than Collegium Pharmaceutical, Inc. (1.80B), greater than Organogenesis Holdings Inc. (550.26M), greater than Lifecore Biomedical, Inc. (400.55M), greater than RedHill Biopharma Ltd. (3.85M), less than Evotec SE (1.30B), less than Supernus Pharmaceuticals, Inc. (2.00B), less than Dr. Reddy's Laboratories Limited (1.04T), less than PetIQ, Inc. (1.30B),

Build a custom stock screener for Taro Pharmaceutical Industries Ltd. (TARO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Taro Pharmaceutical Industries Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Taro Pharmaceutical Industries Ltd. (TARO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Taro Pharmaceutical Industries Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.